2 “Strong Buy” Healthcare Stocks Under $5 With Massive Upside Potential
GSK and J&J alum Vijay Reddy to take control of R&D at Tmunity; Andrew Hirsch exits Agios for CEO job at C4 Therapeutics
Study takes us a step closer to a universal antibody test for COVID-19
AstraZeneca’s Asthma Drug Fasenra Meets Late-Stage Targets; Shares Rise
Unique partnership advances revolutionary CRISPR in a Box educational gene editing kit
Billionaire David Shaw Pours Money Into 3 "Strong Buy" Stocks
Kamada Rises 5% On Initial Phase 1/2 Trial Results For Covid Treatment
A Shot in the Arm
5 things to look for on a college campus that benefit mental health
Scientists develop low-cost chip to detect presence and quantity of COVID-19 antibodies
J&J Gets European Nod For Expanded Blood Cancer Treatment
Dr Reddy's Launches Generic Version Of AstraZeneca's Faslodex In US
Improving European healthcare through cell-based interceptive medicine
Gilead Submits Expanded Application For Yescarta Cancer Treatment
COVID-19 patients suffer long-term lung and heart damage but it can improve with time
AbbVie Inks Deal To Develop, Sell I-Mab’s Cancer Therapy
Compass plans $100m IPO to fund magic mushroom depression drug
Editing the immune response could make gene therapy more effective
CRISPR can help combat the troubling immune response against gene therapy
Too Little is not Enough
A sea-change for pharma? Pandemic commercial models and launch
EU regulators begin fast review of dexamethasone for COVID-19
A ‘Human’ Touch vs. COVID-19
Well Fargo Says These 2 Stocks Could Rally Over 70% From Current Levels
Medtronic’s Organizational Revamp To Cut Costs By Up To $475M
GSK and Vir take COVID-19 antibody therapy into clinic
Mesoblast's Late-Stage Covid-19 Trial Secures Ethics Approval In Australia
Bristol Myers Scores FDA Nod For Acute Myeloid Leukemia Treatment
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
Oxford Biomedica, AstraZeneca Expand Covid-19 Vaccine Supply Deal